VivoSeq
Other

Alcoholism

0

Pipeline Programs↗

1

Active Trials↗

0

Companies Involved↗

Alcoholism is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

90/100

Attrition Rate

8/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

37

clinical trials

Completed28 · 76%
Unknown status5 · 14%
Terminated2 · 5%
Withdrawn1 · 3%
Recruiting1 · 3%

Clinical Trials

Trial Activity

37 trials

SMART-r: Substance Monitoring and Active Relapse Tracking Repository
Recruiting·National Institute on Drug Abuse (NIDA)·N/A·NCT06676059·10,000 enrolled
Serotonin in Alcoholism
Completed·National Institute on Alcohol Abuse and Alcoholism (NIAAA)·N/A·NCT00011752·75 enrolled
Ibogaine in the Treatment of Alcoholism: an Open-label Escalating-dose Trial
Completed·UUniversity of Sao Paulo·Phase 2·NCT03380728·9 enrolled
CRF1 Antagonist GSK561679 in Alcoholism
Completed·National Institute on Alcohol Abuse and Alcoholism (NIAAA)·Phase 2·NCT01187511·44 enrolled
Testing Doxazosin to Treat Stress Mechanisms in Alcoholism
Completed·UUniversity of Wisconsin, Madison·Phase 2·NCT02989493·61 enrolled
Interdisciplinary Study of A Novel Anticonvulsant in Alcoholism
Completed·—·Phase 3·NCT02901041·81 enrolled
Managing Alcoholism in People Who Do Not Respond to Naltrexone
Completed·UUniversity of Pennsylvania·Phase 4·NCT00115037·302 enrolled
Individually Adapted Therapy of Alcoholism
Completed·—·Phase 4·NCT00317031·435 enrolled
Characterizing the Effects of Family History of Alcoholism on Alcohol Analgesia
Completed·UUniversity of Florida·N/A·NCT04925076·125 enrolled
Integrative Therapy in Alcoholism
Completed·HHeinrich-Heine University, Duesseldorf·Phase 4·NCT00159107·371 enrolled
Behavioral Therapy Plus Naltrexone for Alcoholism
Completed·MMedical University of South Carolina·Phase 4·NCT00000456·160 enrolled
Validation of a Test System for Development of Medications for Alcoholism
Completed·TTechnische Universität Dresden·Phase 3·NCT02652585·46 enrolled
Naltrexone Treatment for Alcoholism
Completed·JJohns Hopkins University·Phase 4·NCT00000438·192 enrolled
Genetic and Brain Mechanisms of Naltrexone's Treatment Efficacy for Alcoholism
Completed·MMedical University of South Carolina·Phase 4·NCT00920829·358 enrolled
Medication Development for Protracted Abstinence in Alcoholism: CORT118335 Versus Placebo
Completed·TThe Scripps Research Institute·Phase 2·NCT04466215·50 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)